Rhabdomyosarcoma

Indian Journal of Pediatrics

Volumn 71, Issue 4, 2004, Pages 331-337

  Stuart, Andrea ^a   Radhakrishnan, Jayant ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Children; Rhabdomyosarcoma; Soft tissue sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; IRINOTECAN; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; HISTOPATHOLOGY; HUMAN; PATHOLOGY; PROGNOSIS; RADIATION SICKNESS; REVIEW; RHABDOMYOSARCOMA; SIDE EFFECT; SOFT TISSUE SARCOMA; SURVIVAL RATE;

EID: 2442455570     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02724100     Document Type: Review

References (29)

1. LaQuaglia MP. Rhabdomyosarcoma and Nonrhabdomyomatous Sarcomas. In Oldham KT, Colombani PM, Foglia RP, eds. Surgery of Infants and Children: Scientific Principles and Practice, Philadelphia, PA, Lippincott-Raven, 1997; 615-631.
2. Raney RB, Anderson JR, Barr FG et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study group experience and rationale for Intergroup Rhabdomyosarcoma Study V, J Pediatr Hematol/Oncol 2001; 23: 215-220.
3. Crist W, Gehan EA, Ragab AH et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995; 13: 610-630.
4. Crist WM, Anderson JR, Meza JL et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001; 19: 3091-3102.
5. Maurer HM, Beltangady M, Gehan EA et al. The Intergroup Rhabdomyosarcoma Study-I: A final report. Cancer 1988; 61: 209-20.
6. Maurer HM, Gehan EA, Beltangady M et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993; 71: 1904-22.
7. nd edn. St. Louis, MO 2003, Mosby, Pp. 229-238.
8. th edn. St. Louis, MO, 1998, Mosby, pp 431-445.
9. Newton WA Jr, Hamoudi A, Webber B et al. Pathology of rhabdomyosarcoma and related tumors. In Maurer HM, Ruymann FB, Pochedly C, eds. Rhabdomyosarcoma and Related Tumors in Children and Adolescents, Boca Raton, FL, CRC, 1991, 19-48.
10. Pappo AS, Crist WM, Kuttesch J et al. Tumor-cell DNA content predicts outcome in children and adolescents with Clinical Group III embryonal rhabdomyosarcoma. J Clin Oncol 1993; 11: 1901-1905.
11. Shapiro DN, Parham DM, Douglass EC et al. Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 1991; 9: 159-166.
12. Ruymann FB. Rhabdomyosarcoma in children and adolescents: a review. Hematol Oncol Clin North Am 1987; 1: 621-654.
13. Raney RB Jr. Rhabdomyosarcoma and related tumors of the head and neck in childhood. In Maurer HM, Ruymann FB, Pochedly C, eds. Rhabdomyosarcoma and Related Tumors in Children and Adolescents, Boca Raton, FL, 1991, CRC, 319-332.
14. Gehan E et al. Considerations in the development of a staging system for rhabdomyosarcoma, SIOP XIX Meeting, Jerusalem, 1987.
15. Newton WA, Gehan EA, Webber BL et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification. An intergroup rhabdomosarcoma study. Cancer 1995; 76: 1073-1085.
16. Donaldson SS. Rhabdomyosarcoma: contemporary status and future directions. Arch Surgery 1989; 124: 1015-1020.
17. Crist W, Anderson J, Maurer H et al. Preliminary results for patients with local/regional tumors treated on the Intergroup Rhabdomyosarcoma Study-IV (1991-1997) (abstract 2141). Proc Am Soc Clin Oncol 1999; 18: 555a.
18. Hays DM. New approaches to the surgical management of rhabdomyosarcoma in childhood. Chir Pediatr 1990; 31: 197-201.
19. Lawrence W. Surgical principles in the management of sarcomas in children. In Maurer HM, Ruymann FB, Pochedly C, eds. Rhabdomyosarcoma and Related Tumors in Children and Adolescents, Boca Raton, FL, 1991, CRC, Pp. 171-180.
20. Wiener ES. Rhabdomyosarcoma: New Dimensions in management. Semin Pediatr Surg 1993; 2: 47-58.
21. Hays DM, Lawrence W Jr, Wharam M et al. Primary reexcision for patients with "microscopic residual" following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg 1989; 24: 5-10.
22. Mandell LR. Ongoing progress in the treatment of childhood rhabdomyosarcoma. Oncology 1993; 7: 71-83.
23. Hays DM, Raney RB, Crist WM et al. Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy responsive stage III-IV sarcomas. A report from the Intergroup Rhabdomyosarcoma Study. J Ped Surg 1990; 25: 1100-1105.
24. Wolden SL, Anderson JR, Crist WM et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 1999; 17: 3468-3475.
25. Tefft M. Radiation therapy guidelines in rhabdomyosarcoma: results of the Intergroup Rhabdomyosarcoma Studies. In Maurer HM, Ruymann FB, Pochedly C, eds. Rhabdomyosarcoma and Related Tumors in Children and Adolescents. Boca Raton, FL, CRC 1991; 181-186.
26. Arndt C, Tefft M, Gehan E et al. A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study. J Pediatr Hematol/Oncol 1997; 19: 124-129.
27. Anderson JR, Ruby E, Link M et al. Identification of a favorable subset of patients (pts) with metastatic (MET) rhabdomosarcoma (RMS): A report from the Intergroup Rhabdomyosarcoma Study Group (IRSG) (abstract 1836). Proc Am Soc Clin Oncol 1997; 16: 510a.
28. Kurie JM. The biologic basis for the use of retinoids in cancer prevention and treatment. Cur Opin in Oncol 1999; 11: 497-502.
29. LeRoith D, Baserga R, Helman L et al. Insulin-like growth factors and cancer. Ann. Int Med 1995; 122: 54-59.